Snyder, S E <br/><br/>
Synthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H- benzo[6,7]cyclohepta[1,2,3-ef][3]benzazepine, 6,7-dihydroxy- 1,2,3,4,8,12b-hexahydroanthr[10,4a,4-cd]azepine, and 10-(aminomethyl)-9,10- dihydro-1,2-dihydroxyanthracene as conformationally restricted analogs of beta-phenyldopamine.  [electronic resource] 

 -  Journal of medicinal chemistry  Jun 1995 
 - 2395-409 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-2623 
<br/><br/><label>Standard No.: </label>10.1021/jm00013a015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthracenes--chemical synthesis<br/>Azepines--chemical synthesis<br/>Benzazepines--chemical synthesis<br/>Dopamine--analogs & derivatives<br/>Models, Molecular<br/>Molecular Conformation<br/>Radioligand Assay<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Dopamine--metabolism